(UHS) Universal Health - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9139031002
UHS: Acute Care, Behavioral Health, Outpatient Services, Hospital Management
Universal Health Services, Inc. (NYSE:UHS) operates as a diversified healthcare services provider, managing acute care hospitals, outpatient facilities, and behavioral health centers. The company is organized into two primary business segments: Acute Care Hospital Services and Behavioral Health Care Services. Its acute care hospitals provide a wide range of medical services, including general and specialty surgery, internal medicine, obstetrics, emergency care, radiology, oncology, and pediatric care. Behavioral health services include psychiatric care, substance abuse treatment, and outpatient counseling programs. Additionally, the company offers commercial health insurance services and various management support functions, such as central purchasing, information systems, financial management, and marketing services. Founded in 1978, UHS is headquartered in King of Prussia, Pennsylvania, and has established itself as one of the largest healthcare providers in the U.S., with a significant presence in both acute and behavioral health markets.
Over the next three months, UHS is expected to face headwinds from declining technical momentum, as indicated by its SMA 20 and SMA 50 trending below the current price. The stocks ATR of 7.02 suggests moderate volatility, with potential downside risk targeting the SMA 200 support level of 198.96. However, fundamental analysis points to a P/E ratio of 10.39, below its forward P/E of 9.09, indicating potential undervaluation. The companys P/S ratio of 0.72 reflects a reasonable valuation relative to its revenue, while an RoE of 16.92 underscores strong profitability. These factors could provide a floor for the stock, making it attractive to value investors despite near-term technical weakness.
Additional Sources for UHS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UHS Stock Overview
Market Cap in USD | 11,345m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 1990-03-26 |
UHS Stock Ratings
Growth Rating | 39.2 |
Fundamental | 69.3 |
Dividend Rating | 34.6 |
Rel. Strength | 1.25 |
Analysts | 3.79/5 |
Fair Price Momentum | 160.49 USD |
Fair Price DCF | 424.82 USD |
UHS Dividends
Dividend Yield 12m | 0.44% |
Yield on Cost 5y | 0.83% |
Annual Growth 5y | 31.95% |
Payout Consistency | 56.8% |
UHS Growth Ratios
Growth Correlation 3m | -56.7% |
Growth Correlation 12m | -23.5% |
Growth Correlation 5y | 68.6% |
CAGR 5y | 12.15% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | 1.31 |
Alpha | -5.30 |
Beta | 0.536 |
Volatility | 45.05% |
Current Volume | 1460.2k |
Average Volume 20d | 817.6k |
As of April 30, 2025, the stock is trading at USD 171.88 with a total of 1,460,161 shares traded.
Over the past week, the price has changed by +6.56%, over one month by -8.53%, over three months by -8.07% and over the past year by +2.04%.
Yes, based on ValueRay Fundamental Analyses, Universal Health (NYSE:UHS) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 69.28 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UHS as of April 2025 is 160.49. This means that UHS is currently overvalued and has a potential downside of -6.63%.
Universal Health has received a consensus analysts rating of 3.79. Therefor, it is recommend to hold UHS.
- Strong Buy: 7
- Buy: 1
- Hold: 11
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, UHS Universal Health will be worth about 173.8 in April 2026. The stock is currently trading at 171.88. This means that the stock has a potential upside of +1.13%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 224.6 | 30.7% |
Analysts Target Price | 224.6 | 30.7% |
ValueRay Target Price | 173.8 | 1.1% |